NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Thirona

Thirona

Private
NijmegenHealthcare & Life Scienceshttps://thirona.eu/

Last Round

VC Round

Sep 11, 2023

Total Funding Raised

$4.35M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Thirona is a MedTech company that provides AI-powered software for the analysis of medical images, including thoracic CT scans and retinal images, to aid in the diagnosis and treatment of lung and eye diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Clinical Trials, Computer Vision, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

medical image analysisAI medical imagingpulmonary imagingquantitative image analysisthoracic CT analysisclinical trial imagingimaging biomarkersradiology AIimaging CROcomputer-aided detectionCADtuberculosis detectionchest X-ray AIimage analysis serviceFDA 510(k) clearanceCE certified

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Thirona Comparables

Compare Thirona with similar companies based on industry and business-model similarity.

Thirona comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VIDA Diagnostics
87%
Brainomix
86%
Qure.ai
82%

Thirona Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 11, 2023
GrantJun 26, 2023
SeedOct 28, 2021
GrantMar 26, 2020

Key People

Founding team and executive leadership

Eva van Rikxoort

CEO Founder

Founding Team

Guido Geerts

Co-CEO and partner

Executive Team

Remco Lont

CFO

Executive Team

Rick Philipsen

Chief Operating Officer

Executive Team

Thirona Investors

Notable investors and investment history

Thirona investors
InvestorRounds
European Innovation Council FundGrant
European Regional Development FundGrant
HERAN PartnersSeed, VC Round
StartGreen CapitalSeed, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 12, 2026

    Added ECFS Gene Modifier Working Group as a customer.

  • Mar 10, 2026

    LungQ(R) technology now in over 1,200 hospitals globally.

Thirona Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Thirona Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Thirona's valuation, stock price, and market status.

Firmographic Details

HeadquartersNijmegen
Employee Range88
Year Founded2014
Last FundingSep 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.